Shengxiang Biologics: The nucleic acid detection kit for new coronavirus mutations was approved by the French Ministry of Health for the record

Shanghai Securities News China Securities Network News (reporter Confucius Ziyuan) Shengxiang Biological announcement, the company's product human papillomavirus nucleic acid detection kit (PCR-fluorescent probe method) recently received the "Medical Device Registration Certificate" issued by the State Drug Administration. The product can meet the needs of 1 tube detection and provide 3 kinds of results at the same time - 16 and 18 type and other 13 high-risk types, application scenarios covering outpatient clinics, physical examinations, etc., the launch of this product will provide a more comprehensive and accessible integrated service solution for HPV infection.

Novel coronavirus (SARS-CoV-2) L452R/E484K/K417N mutation nucleic acid detection kit (fluorescent PCR method) has recently obtained the filing permission of the French Ministry of Health, the kit can be used for the preliminary judgment of the Aumecreon variant under the requirements of the French Ministry of Health guidelines, and the test results can determine whether the SARS-CoV-2 infected by patients has L452R, E484K, K417N gene mutations, which can better help the rapid detection and prevention and control of the epidemic.